Search

Your search keyword '"Xiu Yu"' showing total 1,983 results

Search Constraints

Start Over You searched for: Author "Xiu Yu" Remove constraint Author: "Xiu Yu"
1,983 results on '"Xiu Yu"'

Search Results

1. Active Disturbance Rejection Control of Hydraulic Quadruped Robots Rotary Joints for Improved Impact Resistance

2. Protocol for deriving human preimplantation epiblast stem cells and 8-cell embryo-like cells

3. Analysis of the Class 1 Integrons, Carbapenemase Genes and Biofilm Formation Genes Occurrence in Acinetobacter baumannii Clinical Isolates

4. Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma

5. Locus coeruleus tyrosine hydroxylase positive neurons mediated the peripheral and central therapeutic effects of transcutaneous auricular vagus nerve stimulation (taVNS) in MRL/lpr mice

6. Architecture design and implementation of autonomous control system for medium and large unmanned surface ship

8. An 'AND' Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging

9. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling

12. Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome

15. Heat-Induced Epithelial Barrier Dysfunction Occurs via C-Src Kinase and P120ctn Expression Regulation in the Lungs

16. Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance

20. 1st Workshop on Maritime Computer Vision (MaCVi) 2023: Challenge Results

21. Adaptive Improvement of Genetic Algorithms and Their Application in Civil Engineering

26. Ack1: activation and regulation by allostery.

34. Quantifying the anisotropic density structure of the Central Molecular Zone -- a 2D correlation function approach

36. 1st Workshop on Maritime Computer Vision (MaCVi) 2023: Challenge Results.

40. Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

44. The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial

Catalog

Books, media, physical & digital resources